Navigation Links
ABT is the Only Source for Kelo-cote(R) Advanced Formula Scar Gel
Date:6/25/2008

CLEARWATER, Fla., June 25 /PRNewswire/ -- Kelo-cote(R) advanced formula scar gel is a unique patented silicone formula using cross-link technology and has become the gold standard for scar treatment and abnormal scar prevention. The patented silicone formula in Kelo-cote(R) advanced formula scar gel is ONLY available from Advanced Bio-Technologies, Inc.(ABT).

Kelo-cote(R) is no longer available under the Dermatix label. Doctors and customers should not be misled by competitors' claims they offer the same product. Specifically, Valeant Pharmaceutical's claim that Dermatix and Dermatix Ultra contain the same formula or an improvement of Kelo-cote(R) advanced formula scar gel is FALSE. Dermatix and Dermatix Ultra are not manufactured by ABT and neither contains the Kelo-cote(R) formula.

Prior to July 2007, Kelo-cote(R) was available under the Dermatix label, but Valeant's license to market Kelo-cote(R) was terminated. Doctors should be aware that clinical data published under the brand name Dermatix prior to July 2007 was conducted using the current Kelo-cote(R) formula, but Kelo-cote(R) is no longer available under the Dermatix label.

To ABT's knowledge and belief, neither Dermatix nor Dermatix Ultra have clinical evidence supporting its efficacy. Kelo-cote(R) advanced formula scar gel has the ONLY clinically proven patented self-drying silicone formulation that creates a flexible, breathable silicone gel sheet. This is the reason Kelo-cote(R) advanced formula scar gel from ABT is the gold standard for scar treatment and prevention.

Kelo-cote(R) is manufactured by Advanced Bio-Technologies, Inc. headquartered in Clearwater, FL.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Lisa Massaad https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=67863


'/>"/>
SOURCE Advanced Bio-Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Decision Resources, Inc. Acquires Manhattan Research
2. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
3. New discoveries, new labs highlight international Canadian Light Source meeting
4. Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
5. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
6. Engineers demonstrate first room-temperature semiconductor source of coherent Terahertz radiation
7. Eklin Announces Acquisition of Ultrasource, Inc.
8. Treatment with Paliperidone ER May Be Associated with Significantly Reduced Use of Mental Health Resources
9. Global Blood Resources On-Line Calculator Reveals Wasted Blood Costs by Blood Salvage Machines During Heart Surgery to be in the Billions
10. /C O R R E C T I O N from Source -- Resverlogix Corp./
11. ETEX Announces Supply Agreement with AlloSource
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:3/2/2017)... LONDON , March 2, 2017 Summary ... require to better understand Merck KGaA and its partnering ... report: https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals ... into the partnering activity of one of the world,s ... reports are prepared upon purchase to ensure inclusion of ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
Breaking Biology News(10 mins):